NUCLEOLIN and B-cell chronic lymphocytic leukemia: These observations are in agreement with recently described features of CLL that involve altered epigenetic control i.e. the over-expression of nucleolin and its cytoplasmic retention in CLL cells [26] and an altered telomere length in a subset of CLL with a poor prognosis [27].